🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Deeptech life growth solutions provider Acculi Labs raises $1.5 million

IndianStartupNewsIndianStartupNews · 11m ago
Deeptech life growth solutions provider Acculi Labs raises $1.5 million
Medial

Bengaluru-based deep-tech startup, Acculi Labs, has raised $1.5 million in a funding round led by Sabi Holding India. The funds raised will be used to further develop Acculi's Lyra AI insights system and the Lyfas Udyam project, a sustainable agriculture joint venture. Acculi Labs aims to enhance its offerings by focusing on manpower, operational efficiency, infrastructure development, and manufacturing capacity. The startup's flagship product, Lyfas, is a mobile application that captures psychophysiological biomarkers for early diagnostics and monitoring. Additionally, the Lyfas Udyam initiative promotes micro-entrepreneurship by providing small entrepreneurs with the necessary tools and ecosystem.

Related News

Deeptech startup Acculi Labs raises $1.5 Mn

EntrackrEntrackr · 11m ago
Deeptech startup Acculi Labs raises $1.5 Mn
Medial

Acculi Labs, a deep-tech life growth solution provider, has raised $1.5 million in a new investment round at a valuation of $25 million led by Sabi Holding India Ltd. The Bengaluru-based company had earlier raised Rs 5 crore in a seed funding round led by PirE Ventures back in 2020. The fresh fund will be utilized to accelerate the development of its conscious AI insights systems, enhance its manpower, operational efficiency, infrastructure development, Acculi Labs said in a press-release. Co-founded in May 2017 by Rupam Das and Hari Prasath M, Acculi Labs aims to make home-based care available to the patients. The company’s flagship product, Lyfas, enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients and helps them to approach their doctor at an early stage. According to Acculi Labs, it expanded offerings from an initial cardiac health assessment system to a comprehensive suite of health solutions with the launch of Lyfas.The platform claims that its mobile application is capable of non-invasively capturing psychophysiological biomarkers and delivering a detailed health report within three minutes. The company has developed Lyra, a cutting-edge, conscious AI that bridges the gap between carbon and silicon life forms. It has also launched Lyfas Udyam initiative, which provides a micro entrepreneurial circular economy for small entrepreneurs to start and run their businesses, leveraging the ecosystem, processes, and finance.

Cardiotrack raises $2 Mn in pre-series A round

EntrackrEntrackr · 1y ago
Cardiotrack raises $2 Mn in pre-series A round
Medial

Cardiotrack, a provider of data-centric healthcare screening technology and services through health and life insurance providers, has raised $2 million in pre series-A round led by Girish Narasimhan and co-investor Y S Shashidhar. Previously, the firm had raised an angel investment of $1.6 million from a cohort of UHNIs. Founded by Avin Agarwal, Cardiotrack delivers at-home pathology and radiology screening services, in over 300 locations through its pan-India network of diagnostic centers, technicians and phlebotomists equipped with its technology to its health and life insurance customers. Cardiotrack’s unique screening technologies is the equivalent of a treadmill test, being conducted in the comfort of one’s home along with video-based recorded medical examinations. Its medical and IOT grade diagnostics devices, workflow automation and health data digitisation solutions empower health and life insurance providers to offer onboarding experiences while enabling their customers to take control of their health. The Bengaluru-based startup also provides insights into the health of consumers. Currently, it serves nine health and life insurance companies in India.

Redcliffe Labs raises $42 Mn in Series C round

EntrackrEntrackr · 9m ago
Redcliffe Labs raises $42 Mn in Series C round
Medial

Omnichannel diagnostics service provider Redcliffe Labs has raised $42 million in a Series C funding round led by Denmark-based investment firm IFU, which contributed $20 million. Existing investor LeapFrog added $15 million, while the remaining capital came from shareholders HealthQuad and Spark Growth Ventures. This new funding follows the Noida-based company’s previous rounds, including $61 million in its Series B in May 2022 and $10 million in Series A in April 2021. Other notable investors include Schroders, LC Nueva, Chiratae Ventures, and Alkemi Venture Partners. The fresh capital will fuel Redcliffe’s expansion plans, particularly in deepening its presence in tier II and III cities across India. The company plans to open more labs and collection centers and expand its home collection network, according to a press release. Redcliffe has executed strategic acquisitions in North-Western India and continues to pursue PAN-India expansion through partnerships and further acquisitions. In addition to its financial growth, Redcliffe has strengthened its leadership. Ankur Shah, former chief finance and strategy officer of Careem (acquired by Uber), has joined as an independent director. Alka Saxena, formerly of Health Care at Home and Dr. Lal PathLabs, has been appointed as CFO. Currently, Redcliffe Labs’ services are available in more than 220 cities across India through a network of 80 labs, over 2,000 collection centers, and home collection services. The company claims to have served more than 7 million patients across tier I, II, and III cities. Redcliffe Labs’ operating revenue surged 2.6 times to Rs 347 crore in FY23, up from Rs 130 crore in FY22. However, the company’s losses jumped fivefold to Rs 345.6 crore from Rs 67.7 crore over the same period. It competes with notable players such as PharmEasy-owned Thyrocare, Healthians, 1mg, and Dr. Lal PathLabs.

Download the medial app to read full posts, comements and news.